First-line immune checkpoint inhibitors in low programmed death-ligand 1-expressing population

• Main Authors: Feiyang Zhang (Author), Guoming Chen (Author), Yixin Yin (Author), Xiaojiang Chen (Author), Runcong Nie (Author), Yingbo Chen (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Inhibitors of programmed cell death 1 (PD1) and its ligand (PDL1) have exhibited favorable long-term survival in many types of advanced-stage cancer and current approvals have to date been granted in certain tumour types irrespective of PD-L1 status.Methods: We extracted the following...